We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AGL market cap is 700.43M. The company's latest EPS is USD -0.6373 and P/E is -2.73.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.15B | 1.22B | 815.5M | 1.6B | 1.48B |
Operating Income | -29.82M | -24.46M | -167.62M | -1.49M | -33.39M |
Net Income | -16.75M | -31.44M | -230.43M | -6.06M | -30.68M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 794.41M | 1.22B | 1.83B | 2.71B | 4.32B |
Operating Income | -106.57M | -56.67M | -393.95M | -120.43M | -215.64M |
Net Income | -282.59M | -60.05M | -406.49M | -106.55M | -262.6M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.35B | 2.28B | 1.74B | 2.32B | 2.16B |
Total Liabilities | 1.47B | 1.41B | 1.08B | 1.63B | 1.49B |
Total Equity | 879.45M | 871.6M | 661.02M | 688.49M | 675.87M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 402.79M | 446.36M | 1.59B | 1.7B | 1.74B |
Total Liabilities | 353.82M | 421.59M | 494.66M | 656.86M | 1.08B |
Total Equity | -232.03M | -284.73M | 1.09B | 1.04B | 661.02M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -82.02M | -95.03M | -156.2M | -47.78M | -66.49M |
Investing | -30.78M | -41.82M | -44.02M | 51.44M | 69.66M |
Financing | -193.7M | -192.29M | -193.13M | 559k | -1.16M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -131.18M | -53.2M | -148.16M | -130.81M | -156.2M |
Investing | -5.06M | 22.07M | -90.51M | -444.39M | -44.02M |
Financing | 176.3M | 24.62M | 1.15B | 28.06M | -193.13M |
Market Cap | 700.43M |
Price to Earnings Ratio | -2.73 |
Price to Sales Ratio | 0.17 |
Price to Cash Ratio | 6.66 |
Price to Book Ratio | 1.08 |
Dividend Yield | - |
Shares Outstanding | 412.02M |
Average Volume (1 week) | 3.8M |
Average Volume (1 Month) | 4.86M |
52 Week Change | -84.47% |
52 Week High | 13.76 |
52 Week Low | 1.50 |
Spread (Intraday) | 0.01 (0.59%) |
Company Name | Agilon Health inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.agilonhealth.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions